Berardi A - Search Results

1

Kogon MM, Jasiukaitis P, Berardi A, Gupta M, Kosslyn SM, Spiegel D. Kogon MM, et al. Among authors: berardi a. Int J Clin Exp Hypn. 1998 Oct;46(4):363-70. doi: 10.1080/00207149808410015. Int J Clin Exp Hypn. 1998. PMID: 9780527

2

Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated.

Leproult R, Colecchia EF, Berardi AM, Stickgold R, Kosslyn SM, Van Cauter E. Leproult R, et al. Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R280-90. doi: 10.1152/ajpregu.00197.2002. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 12529281 Free article. Clinical Trial.

3

Brain mechanisms in human classical conditioning: a PET blood flow study.

Hugdahl K, Berardi A, Thompson WL, Kosslyn SM, Macy R, Baker DP, Alpert NM, LeDoux JE. Hugdahl K, et al. Among authors: berardi a. Neuroreport. 1995 Sep 11;6(13):1723-8. doi: 10.1097/00001756-199509000-00005. Neuroreport. 1995. PMID: 8541468

4

Face and word memory differences are related to patterns of right and left lateral ventricle size in healthy aging.

Berardi A, Haxby JV, De Carli C, Schapiro MB. Berardi A, et al. J Gerontol B Psychol Sci Soc Sci. 1997 Jan;52B(1):P54-61. doi: 10.1093/geronb/52b.1.p54. J Gerontol B Psychol Sci Soc Sci. 1997. PMID: 9008675

5

Overall vigilance and sustained attention decrements in healthy aging.

Berardi A, Parasuraman R, Haxby JV. Berardi A, et al. Exp Aging Res. 2001 Jan-Mar;27(1):19-39. doi: 10.1080/03610730126014. Exp Aging Res. 2001. PMID: 11205528

6

Sustained attention in mild Alzheimer's disease.

Berardi AM, Parasuraman R, Haxby JV. Berardi AM, et al. Dev Neuropsychol. 2005;28(1):507-37. doi: 10.1207/s15326942dn2801_4. Dev Neuropsychol. 2005. PMID: 15992254 Free PMC article.

7

Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the Alzheimer type.

Raffaele KC, Berardi A, Morris PP, Asthana S, Haxby JV, Schapiro MB, Rapoport SI, Soncrant TT. Raffaele KC, et al. Among authors: berardi a. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(5):643-8. doi: 10.1016/0278-5846(91)90054-5. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1956992

8

Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's disease.

Raffaele KC, Asthana S, Berardi A, Haxby JV, Morris PP, Schapiro MB, Soncrant TT. Raffaele KC, et al. Among authors: berardi a. Neuropsychopharmacology. 1996 Aug;15(2):163-70. doi: 10.1016/0893-133X(95)00179-H. Neuropsychopharmacology. 1996. PMID: 8840352 Clinical Trial.

9

Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

Soncrant TT, Raffaele KC, Asthana S, Berardi A, Morris PP, Haxby JV. Soncrant TT, et al. Among authors: berardi a. Psychopharmacology (Berl). 1993;112(4):421-7. doi: 10.1007/BF02244889. Psychopharmacology (Berl). 1993. PMID: 7871052 Clinical Trial.

10

Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.

Asthana S, Raffaele KC, Berardi A, Greig NH, Haxby JV, Schapiro MB, Soncrant TT. Asthana S, et al. Among authors: berardi a. Alzheimer Dis Assoc Disord. 1995 Winter;9(4):223-32. Alzheimer Dis Assoc Disord. 1995. PMID: 8749612 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters